Q and A: Advances in screening for colon cancer
DEAR MAYO CLINIC: A friend of mine passed away recently after receiving a colon cancer diagnosis. Who is at risk for this cancer, and should I be screened?
Jan 3, 2023
0
174
MeSH tree: E01.370.372.250.250.200
DEAR MAYO CLINIC: A friend of mine passed away recently after receiving a colon cancer diagnosis. Who is at risk for this cancer, and should I be screened?
Jan 3, 2023
0
174
People with Lynch syndrome have a higher hereditary risk of colon cancer. Despite regular endoscopic surveillance, it remains elevated in those affected. Researchers at the National Center for Hereditary Tumor Diseases (NZET) ...
Dec 28, 2022
0
83
Regular screening is one of the most important ways to prevent colorectal cancer (colon and rectal).
Dec 8, 2022
0
119
As doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new research has found those at a higher risk of the disease would likely need to be convinced ...
Dec 7, 2022
0
45
A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals with average risk for the disease reported finding no colorectal cancers ...
Nov 29, 2022
0
77
While screening by Fecal Immunochemical Test (FIT) can detect colorectal cancers early, successful treatment depends on the patient undergoing follow-up colonoscopy after an unfavorable test result.
Nov 29, 2022
0
71
Use of the Personal Health Record for Colorectal Cancer Survivors, a new online tool specifically tailored to meet the needs of and make support available for the more than 1.5 million individuals in the U.S. with a history ...
Nov 3, 2022
0
34
A recently published study in a high-profile medical journal appeared to call into question the efficacy of colonoscopy, a proven and widely utilized strategy for the screening and prevention of colorectal cancer.
Oct 20, 2022
0
56
Commercially available noninvasive screening tests for colorectal cancer—a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard®)—are equally effective for screening patients with early-stage ...
Oct 16, 2022
0
139
Despite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physicians and clinicians across the U.S. say the procedure remains the best and most proven way to detect cancer and prevent ...
Oct 14, 2022
0
91